KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) Debt to Equity: 2009-2025

Historic Debt to Equity for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $0.78.

  • Quest Diagnostics' Debt to Equity fell 14.86% to $0.78 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.78, marking a year-over-year decrease of 14.86%. This contributed to the annual value of $0.91 for FY2024, which is 22.79% up from last year.
  • Latest data reveals that Quest Diagnostics reported Debt to Equity of $0.78 as of Q3 2025, which was down 0.38% from $0.78 recorded in Q2 2025.
  • Quest Diagnostics' 5-year Debt to Equity high stood at $0.91 for Q3 2024, and its period low was $0.59 during Q1 2021.
  • For the 3-year period, Quest Diagnostics' Debt to Equity averaged around $0.76, with its median value being $0.74 (2023).
  • In the last 5 years, Quest Diagnostics' Debt to Equity decreased by 16.51% in 2021 and then soared by 38.96% in 2024.
  • Over the past 5 years, Quest Diagnostics' Debt to Equity (Quarterly) stood at $0.62 in 2021, then increased by 8.45% to $0.67 in 2022, then increased by 10.72% to $0.74 in 2023, then rose by 22.79% to $0.91 in 2024, then declined by 14.86% to $0.78 in 2025.
  • Its Debt to Equity was $0.78 in Q3 2025, compared to $0.78 in Q2 2025 and $0.84 in Q1 2025.